Analyst Research
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Solta Medical Inc Issues FY 2013 Guidance Above Analysts' Estimates; Issues H1 2013 EBIT Guidance Above Analysts' Estimates
Solta Medical Inc announced that for fiscal 2013, it expects revenue to grow by 26% to 32% and be in the range of $182 million to $191 million and Non-GAAP operating income to be in the range of $13 million to $16 million. For the first half of 2013, it expects non-GAAP operating income to be in the range $3 million to $4 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $164 million and EBIT of $8 million for fiscal 2013; EBIT of $(0.27) million for the first quarter of 2013 and EBIT of $1.85 million for the second quarter of 2013.
Latest Developments for Solta Medical Inc
- Solta Medical Inc Lowers FY 2013 Revenue Guidance; Reaffirms FY 2013 EBIT Guidance; Reaffirms H1 2013 EBIT Guidance
- Solta Medical Inc Completes Acquisition Of Sound Surgical Technologies
- Solta Medical Inc to Acquire Sound Surgical Technologies LLC
- Solta Medical Inc Issues Q4 2012 Guidance Below Analysts' Estimates; Raises FY 2012 Revenue Guidance
Latest Key Developments in Advanced
- Volcano Corp Announces Preliminary Results From ADVISE II Study
- Nordion Inc Enters Into Agreement To Divest Targeted Therapies Business To BTG Plc
- Raysearch Laboratories AB publ Appoints Ernst & Young as Auditors
- Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
- Share this
- Link this
- Digg this
Follow Reuters